The Future of Stem Cells

Connecticut as a Hub for Research

<< Previous
0 of 1 Images
Next >>
Dr. Laura Grabel, Lauren B. Dachs Professor of Science in Society at Wesleyan University
Photo:Chion Wolf
Paul Pescatello, President and CEO, CURE, an educational and business support network organization for bioscience in Connecticut
Photo:Chion Wolf
Dr. Caroline Dealy, Associate Professor, University of Connecticut and the Co-Founder and CEO of Chondrogenics
The Future of Stem Cells
Download Audio
Audio Playlist
The Future of Stem Cells


Stem cells are the Wild West of biomedicine.
The commercially run SpaceX Dragon capsule just delivered mouse stem cells to the International Space Station, part of an experiment to see how long periods in space affect living organisms.
In Scotland, researchers are attempting to make blobs of stem cells in a three-d printer.
And in Italy, terminally ill patients are being given an untested, unproven and theoretically risky stem cell treatment over the protests of scientists.
Here in Connecticut, things are a little tamer, but we were fairly early out of the gate with a state stem cell program. Most of what goes on here is pure research, but there are therapies under development that would treat macular degeneration and osteoarthritis.
On the even of the state's annual StemConn conference and tradeshow, let's meet some of the players. 
Leave your comments below, email us, or tweet us @wnprcolin.



Christine writes:

Please repeat the name of the research facility that has the trials for Macular Degeneration. My mom is blinded by this.